AdityaJulooriMD

Assistant Professor, The University of Chicago

Dr. Juloori is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

PubMed

Neoadjuvant Nivolumab Plus Chemotherapy Followed by Response-Stratified Chemoradiation Therapy in HPV-Negative Head and Neck Cancer: The DEPEND Phase 2 Nonrandomized C...
Ari J Rosenberg, Aditya Juloori, Michael J Jelinek, Nishant Agrawal, John F Cursio
JAMA Oncology. 2025-03-06
Analysis of AI foundation model features decodes the histopathologic landscape of HPV-positive head and neck squamous cell carcinomas.
Hanna M Hieromnimon, Anna Trzcinska, Frank T Wen, Frederick M Howard, James M Dolezal
Oral Oncology. 2025-03-04
NCCN Guidelines® Insights: Head and Neck Cancers, Version 2.2025.
A Dimitrios Colevas, Anthony J Cmelak, David G Pfister, Sharon Spencer, Douglas Adkins
Journal of the National Comprehensive Cancer Network. 2025-02-01

Journal Articles

Definitive Chemoradiation in Locally Advanced Squamous Cell Carcinoma of the Hypopharynx: Long-Term Outcomes and Toxicity
Brian B Burkey, Neil M Woody, John F Greskovich, David J Adelstein, Aditya Juloori, Shlomo A Koyfman, Joseph Scharpf, Brandon Prendes, Anticancer Research